Shanghai-based BVCF, a growth capital-focused private equity fund specializing in the life sciences industry, has completed a final close of its third fund, raising a total of US$200 million, according to media reports.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?